Herpes Zoster Vaccine clinical trials
How each study uses Herpes Zoster Vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Herpes Zoster Vaccine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 2
GlaxoSmithKline (3) · University of Alabama at Birmingham (1) · Changchun BCHT Biotechnology Co. (1) · University of Toronto (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Herpes Zoster Vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and OlderNot yet recruitingPhase 4Changchun BCHT Biotechnology Co.NCT06961721Written as Herpes Zoster Vaccine, Live
- Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)CompletedPhase 2University of Alabama at BirminghamNCT02538341Written as Herpes Zoster (HZ) Vaccine
- Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of AgeCompletedPhase 3GlaxoSmithKlineNCT02075515Written as Herpes Zoster vaccine (GSK 1437173A)
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes ZosterCompletedPhase 3GlaxoSmithKlineNCT01827839Written as Herpes Zoster vaccine (GSK1437173A)
- Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersCompletedPhase 3GlaxoSmithKlineNCT01767467Written as Herpes zoster vaccine (GSK 1437173A)
- Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus VaccineStatus unknownPhase 4University of TorontoNCT02514018Written as Live-attenuated varicella-zoster virus vaccine